Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

'New/Designer Benzodiazepines': an analysis of the literature and psychonauts' trip reports.

Orsolini L, Corkery JM, Chiappini S, Guirguis A, Vento A, De Berardis D, Papanti D, Schifano F.

Curr Neuropharmacol. 2020 Jan 10. doi: 10.2174/1570159X18666200110121333. [Epub ahead of print]

PMID:
31933443
2.

The clinical challenges of synthetic cathinones.

Schifano F, Napoletano F, Arillotta D, Zangani C, Gilgar L, Guirguis A, Corkery JM, Vento A.

Br J Clin Pharmacol. 2019 Nov 1. doi: 10.1111/bcp.14132. [Epub ahead of print]

PMID:
31674690
3.

The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review.

Orsolini L, Chiappini S, Corkery JM, Guirguis A, Papanti D, Schifano F.

Expert Rev Neurother. 2019 Dec;19(12):1253-1264. doi: 10.1080/14737175.2019.1666712. Epub 2019 Sep 24.

PMID:
31503507
4.

Assessing the 2004-2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems.

Schifano F, Chiappini S, Corkery JM, Guirguis A.

Front Pharmacol. 2019 Feb 1;10:46. doi: 10.3389/fphar.2019.00046. eCollection 2019.

5.

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions.

Schifano F, Chiappini S, Corkery JM, Guirguis A.

Int J Neuropsychopharmacol. 2019 Apr 1;22(4):270-277. doi: 10.1093/ijnp/pyz007.

6.

Psychedelic Fauna for Psychonaut Hunters: A Mini-Review.

Orsolini L, Ciccarese M, Papanti D, De Berardis D, Guirguis A, Corkery JM, Schifano F.

Front Psychiatry. 2018 May 22;9:153. doi: 10.3389/fpsyt.2018.00153. eCollection 2018. Review.

7.

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.

Schifano F, Chiappini S, Corkery JM, Guirguis A.

Brain Sci. 2018 Apr 22;8(4). pii: E73. doi: 10.3390/brainsci8040073. Review.

8.

Exploration of the Use of New Psychoactive Substances by Individuals in Treatment for Substance Misuse in the UK.

Gittins R, Guirguis A, Schifano F, Maidment I.

Brain Sci. 2018 Mar 30;8(4). pii: E58. doi: 10.3390/brainsci8040058.

9.

The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.

Orsolini L, Papanti GD, De Berardis D, Guirguis A, Corkery JM, Schifano F.

Front Psychiatry. 2017 Nov 20;8:240. doi: 10.3389/fpsyt.2017.00240. eCollection 2017. Review.

10.

New psychoactive substances: a public health issue.

Guirguis A.

Int J Pharm Pract. 2017 Oct;25(5):323-325. doi: 10.1111/ijpp.12313. No abstract available.

PMID:
28895252
11.

Intended and unintended use of cathinone mixtures.

Guirguis A, Corkery JM, Stair JL, Kirton SB, Zloh M, Schifano F.

Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2598. Review.

PMID:
28657191
12.

Method development for the determination of elements in Hypericum perforatum L. (St John's wort) herb and preparations using inductively coupled plasma-optical emission spectroscopy and microwave digestion.

Owen JD, Evans SJ, Guirguis A, Kellett K, Stair JL.

J Pharm Pharmacol. 2019 Jan;71(1):38-45. doi: 10.1111/jphp.12742. Epub 2017 May 31.

PMID:
28560741
13.

Identification of new psychoactive substances (NPS) using handheld Raman spectroscopy employing both 785 and 1064nm laser sources.

Guirguis A, Girotto S, Berti B, Stair JL.

Forensic Sci Int. 2017 Apr;273:113-123. doi: 10.1016/j.forsciint.2017.01.027. Epub 2017 Feb 4.

PMID:
28260646

Supplemental Content

Loading ...
Support Center